Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
All of Us Program Looking to Public-Private Partnerships, Other Funding Amid Budget Uncertainty
Premium
In a report, a working group cautioned that the program must lessen its reliance on congressional appropriations or risk "squandering" investments made so far.
House E&C Committee Passes Bill on Rare Pediatric Disease Drug Development
The bill's passage through the committee improves the rare pediatric disease priority review voucher program's chances of being reauthorized before it expires Sept. 30.
AMP Sues FDA Over Laboratory-Developed Test Final Rule
Filed in the US District Court for the Southern District of Texas, the lawsuit is the second legal challenge to the rule following a suit filed by ACLA in June.
The rule could force labs to shed tests deemed nonessential to their institutions' missions as well as influence decisions around instrumentation and vendor choices.
Allarity Therapeutics Facing Potential Legal Action for Violation of SEC Laws
The SEC warned of enforcement action regarding Allarity's disclosures about FDA interactions seeking approval for dovitinib and its companion diagnostic.